Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
Lancet 390 , 15111520 (2017)
However, despite promising preclinical results, the clinical translation of SIN is limited by its poor pharmacokinetic profile, including low oral bioavailability and rapid systemic clearance
The case for aggressive pricing may also reflect underlying market dynamics
Managing Side Effects Nausea, vomiting, and reduced appetite are most common during dose escalation
Glutathione peroxidase (GPx) and superoxide dismutase (SOD) in oropharyngeal cancer associated with EBV and HPV coinfection
Manufacturers can choose to collaborate with strong and reputable distributors to jointly develop sales strategies and marketing plans
US$ 23.50
US$ 23.00
US$ 21.50
US$ 22.98
US$ 28.70
US$ 24.27
